Tom Essaye, The Sevens Report founder interviewed with Yahoo Finance’s Brian Sozzi and Alexis Christoforous discussing the market action, jobless claims, earnings and more. Click here to watch the full interview.
“The historic drop by front month oil futures was largely due to logistical issues in the physical market, namely lack of available storage…” wrote Tom Essaye, founder of The Sevens Report. Click here to read the full article.
“Looking ahead, it’s still all about demand for oil right now, and so far there is little evidence to support the idea…” said Tom Essaye, founder of The Sevens Report. Click here to read the full article.
“The oil market is sending a bold warning that economic growth may not recover nearly as quickly as some equity investors would hope…” wrote Tom Essaye, president of the Sevens Report, in a Tuesday note to clients. Click here to read the full article.
“The oil market is sending a bold warning that economic growth may not recover nearly as quickly as some equity investors would hope,” wrote Tom Essaye, president of the Sevens Report, in a Tuesday note to clients. “The S&P 500 is pricing a relatively quick return to a normal economy…” Click here to read the full article.
“The historic drop by front month oil futures was largely due to logistical issues in the physical market, namely lack of available storage, paired with futures expiration looming…” wrote Tom Essaye, founder of The Sevens Report. Click here to read the full article.
“This will be a unique earnings season,” Tom Essaye, a former Merrill Lynch trader who founded the “Sevens Report” newsletter, wrote in a note. “But it remains critically important because it’ll give us microeconomic insight into the question of ‘How bad is the damage?’…Click here to read the full article.
Tom Essaye interviewed with Ben Lichtenstein from TD Ameritrade. Click here to read the full article.
Tom Essaye, founder of The Sevens Report, said the volatility in the market is not yet over and said the market changes await events such as final approval of the stimulus package.
“We also need to see more progress on the pharma side of things and above all else…” Essaye said. Click here to read the full article.
